A Case of Choroidal Osteoma with Subretinal Hemorrhage Improved by Intravitreal Bevacizumab and Aflibercept Injections. |
Charm Kim, Kyung Seek Choi, Hae Jung Sun |
Department of Ophthalmology, Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea. sunhj99@schmc.ac.kr |
유리체 내 베바시주맙 및 애플리버셉트 주사를 통해 호전된 망막하출혈을 동반한 맥락막골종 1예 |
김 참⋅최경식⋅선해정 |
순천향대학교 의과대학 서울병원 안과학교실 |
Correspondence:
Hae Jung Sun, Email: sunhj99@schmc.ac.kr |
Received: 7 June 2018 • Revised: 24 July 2018 • Accepted: 27 September 2018 |
Abstract |
PURPOSE To report a case of choroidal osteoma (CO) complicated by extensive subretinal hemorrhage treated with intravitreal bevacizumab and aflibercept injections. CASE SUMMARY: A 42-year-old female patient presented with decreased visual acuity and a temporal visual field defect in the left eye. The patient had a history of retinal hemorrhage in the left eye 3 years prior, which improved without any treatment. The patient's visual acuity had decreased to 0.6 at the initial visit. On fundus examination, orange-colored elevated lesions involving the superior peripapillary area with massive subretinal hemorrhage extending to the macular area were revealed. Optical coherence tomography, fluorescein angiography, and B-scan ultrasonography results indicated CO complicated by choroidal neovascularization (CNV). With multiple intravitreal injections of bevacizumab and aflibercept (bevacizumab ×1, aflibercept ×2), the patient's visual acuity improved and the CNV lesion was kept stable without recurrence as of the 1-year follow-up visit. CONCLUSIONS: Intravitreal bevacizumab and aflibercept injections can be helpful in the treatment of CO complicated by CNV, by improving visual acuity and the retinal anatomy. |
Key Words:
Aflibercept;Bevacizumab;Choroidal osteoma;Subretinal hemorrhage |